A new co-innovation lab in the San Francisco Bay area will see Lilly and NVIDIA scientists work alongside each other to fuel ...

Anthropic has introduced Claude for Healthcare, a suite of artificial intelligence (AI)-based tools to assist healthcare ...

The BEST division, a subsidiary of Bruker, has confirmed two multi-year MRI superconductor supply agreements with global ...

Haemonetics has acquired Vivasure, a developer of next-generation technology for percutaneous vessel closure, in a deal worth ...

Enodia Therapeutics has raised $25m in seed funding to advance a small-molecule platform for targeted protein degradation ...

The US Food and Drug Administration (FDA) is moving to relax regulatory requirements for low risk health and wellness ...

CSA Medical has submitted a PMA application for its RejuvenAir System, a device-based therapy intended to treat chronic ...

NAMSA has acquired select assets of Labcorp’s early development medical device testing business, aligning with .

Medical Devices includes a session from a regulatory expert on how companies can align their research between regions.

BrightHeart has raised €11m ($12.8m) to advance commercialisation efforts for its AI-based prenatal congenital heart defect ...

STAAR Surgical is terminating its agreement to merge with Swiss eyecare specialist Alcon in a $1.6bn deal, ending a ...

Ceribell’s LVO Stroke tool is underpinned by the same EEG monitoring technology used in its seizure and delirium monitoring ...